Figure 1.
Top: Proportion (95% CI) of participants engaged in antiretroviral therapy care at each follow-up period, stratified by ≥daily cannabis use. Bottom: Proportion (95% CI) of antiretroviral therapy-exposed participants reaching viral suppression at each follow-up period, stratified by ≥daily cannabis use.